Clearbridge Investments LLC trimmed its position in Novanta Inc. (NASDAQ:NOVT – Free Report) by 46.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 164,576 shares of the technology company’s stock after selling 142,326 shares during the period. Clearbridge Investments LLC owned about 0.46% of Novanta worth $25,142,000 at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. Empowered Funds LLC acquired a new stake in shares of Novanta in the fourth quarter worth approximately $26,000. SBI Securities Co. Ltd. acquired a new stake in Novanta during the 4th quarter worth $97,000. Venturi Wealth Management LLC grew its holdings in shares of Novanta by 6,500.0% during the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the technology company’s stock worth $111,000 after buying an additional 715 shares in the last quarter. KBC Group NV grew its holdings in shares of Novanta by 41.6% during the fourth quarter. KBC Group NV now owns 1,500 shares of the technology company’s stock worth $229,000 after buying an additional 441 shares in the last quarter. Finally, Sanctuary Advisors LLC acquired a new stake in shares of Novanta in the third quarter valued at about $232,000. 98.35% of the stock is currently owned by hedge funds and other institutional investors.
Novanta Price Performance
NASDAQ:NOVT opened at $127.50 on Wednesday. The stock has a 50 day moving average price of $142.00 and a 200 day moving average price of $157.94. The stock has a market cap of $4.59 billion, a PE ratio of 76.35 and a beta of 1.34. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.81 and a current ratio of 2.79. Novanta Inc. has a one year low of $125.42 and a one year high of $187.12.
Wall Street Analyst Weigh In
Separately, Robert W. Baird dropped their price objective on shares of Novanta from $169.00 to $160.00 and set a “neutral” rating for the company in a research note on Monday, March 3rd.
View Our Latest Research Report on NOVT
About Novanta
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Featured Stories
- Five stocks we like better than Novanta
- Pros And Cons Of Monthly Dividend Stocks
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- How to invest in marijuana stocks in 7 stepsĀ
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.